HME industry mergers and acquisitions firm Vertess touts closing four industry transactions during Q2 and Q3.
While COVID-19 might have been a gut punch for many sectors of the U.S. economy, mergers and acquisitions in the HME market is not one of them.
Healthcare M&A advisory firm VERTESS reported that it closed four major HME industry transactions in Q2 and Q3, regardless of the pandemic. Managing Director Bradley Smith said in a public statement the company has closed several transitions this year.
"Even in the face of adversity that is 2020, I am thrilled to have helped deserving owners successfully exit their businesses while also helping bridge the gap for these healthcare providers to extend their established platforms," he stated.
Recently closed deals involving VERTESS include:
About the Author
David Kopf is the Publisher and Executive Editor of HME Business and DME Pharmacy magazines. Follow him on LinkedIn at linkedin.com/in/dkopf/ and on Twitter at @postacutenews.
Contact the Editor.